Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 421
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07113925 | A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies | ||
| NCT06768632 | Bioequivalence Test of Eltrombopag Olamine Tablets in Humans Under Fasting State | ||
| NCT05193604 | A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | ||
| NCT05029076 | Human Bioequivalence Test of Liraglutide Injection | ||
| NCT06434467 | The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma | ||
| NCT02029209 | To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT03099330 | A Phase I Study of TQ-B3139 on Tolerance and Pharmacokinetics | ||
| NCT05959694 | A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) . | ||
| NCT05493995 | A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer. | ||
| NCT04203719 | A Study of Anlotinib and AK105 Injection in Subjects With Advanced Head, Neck and Chest Cancer | ||
| NCT03527888 | Study of Anlotinib in Patients With Primary Malignant Bone Tumors | ||
| NCT03910127 | Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（NSCLC） | ||
| NCT04009317 | Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT06351150 | Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock | ||
| NCT07291050 | A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 Tablets in Subjects With Advanced Malignant Tumors | ||
| NCT04805060 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant Tumors | ||
| NCT02622932 | Study to Investigate the Absorption, Metabolism and Excretion of [14C] Anlotinib in Patients With Advanced Cancer Patients | ||
| NCT05020652 | A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis | ||
| NCT06552520 | To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis | ||
| NCT07187960 | Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma | ||
| NCT05487976 | Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor | ||
| NCT03019276 | A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics | ||
| NCT04128085 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors | ||
| NCT05640804 | A Bioequivalence Study of Dasatinib Tablet | ||
| NCT04007835 | Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI | ||
| NCT03706287 | Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC | ||
| NCT04180150 | A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B | ||
| NCT06188624 | Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers | ||
| NCT06211751 | A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy | ||
| NCT06198751 | A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer | ||
| NCT04895345 | A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma | ||
| NCT04952493 | Anlotinib or Penpulimab in Combination With RAI for DTC | ||
| NCT07156643 | A Prospective, Single-arm, Multicenter Exploratory Clinical Study of Anlotinib Combined With Bempegaldesleukin and Conventional Chemoradiotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma. | ||
| NCT02944864 | A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics | ||
| NCT07293390 | A Clinical Trial of Mass Balance of [14C] TQ05105 in Healthy Chinese Subjects | ||
| NCT06431490 | A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer | ||
| NCT05815862 | Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer | ||
| NCT05346952 | A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the Treatment of First-line Non-squamous Non-small Cell Lung Cancer(NSCLC). | ||
| NCT06122831 | A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF) | ||
| NCT05198505 | Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors | ||
| NCT04216082 | A Study of Anlotinib in Subjects With Advanced Malignancy | ||
| NCT06415903 | A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer | ||
| NCT04405505 | A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC) | ||
| NCT06449859 | A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects | ||
| NCT03850873 | A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics | ||
| NCT05333276 | Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced Cancers | ||
| NCT06156280 | A Clinical Study of TQH2929 in Healthy Adult Subjects | ||
| NCT05494060 | XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma | ||
| NCT04854668 | A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer | ||
| NCT06010537 | Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle |
